Lv7
5000 积分 2021-09-30 加入
Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract
5个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
6个月前
已完结
Discovery of (S)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain
8个月前
已完结
LEVOMILNACIPRAN--A SUCCESSOR OF MILNACIPRAN WITH A HIGHER NORADRENERGIC SELECTIVITY
10个月前
已关闭
TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception
1年前
已完结
Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826
1年前
已完结
Selective Inhibition of NaV1.8 with VX-548 for Acute Pain
1年前
已完结
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis
1年前
已完结
TARGETING SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
1年前
已完结
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
1年前
已关闭
皖公网安备34019202002308
